Total Funding
27
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Asterion develops patient-friendly drugs for the treatment of serious chronic and acute disorders.
About the Company
Asterion is to design and develop superior, patient-friendly drugs for the treatment of serious chronic and acute disorders. Their patented technologies and products offer the promise of long-acting potent biopharmaceuticals that will require less frequent administration than existing marketed drugs. These products have the potential to improve
healthcare outcomes and offer other potential benefits in terms of efficacy, side effect profile, compliance and manufacture.
